Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1B | Q00975 | 17/20 | 0.40 |
| ▸ | NR1I2 | O75469 | 6/20 | 0.40 |
| ▸ | CCR1 | P32246 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | F2 | P00734 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4282396 | 0.84 | CACNA1B (0.51) | CACNA1BNR1I2CYP3A4 | |
| SCHEMBL4277906 | 0.84 | CACNA1B (0.51) | CACNA1BNR1I2CYP3A4 | |
| SCHEMBL4280157 | 0.82 | CACNA1B (0.60) | CACNA1BNR1I2CYP3A4 | |
| SCHEMBL4278747 | 0.82 | CACNA1B (0.60) | CACNA1BNR1I2CYP3A4 | |
| SCHEMBL4277799 | 0.82 | CACNA1B (0.60) | CACNA1BNR1I2CYP3A4 | |
| SCHEMBL4285271 | 0.80 | HTR2A (0.45) | CACNA1BNR1I2CCR1CYP3A4F2 | |
| SCHEMBL4277967 | 0.80 | HTR2A (0.45) | CACNA1BNR1I2CCR1CYP3A4F2 | |
| SCHEMBL4277963 | 0.80 | CACNA1B (0.48) | CACNA1BNR1I2CYP3A4 | |
| SCHEMBL4282559 | 0.80 | CACNA1B (0.42) | CACNA1BNR1I2CCR1F2 | |
| SCHEMBL4282565 | 0.80 | CACNA1B (0.42) | CACNA1BNR1I2CCR1F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101044116-A | 4-phenylsulfonamidopiperidines as calcium channel blockers | EURO CELTIQUE SA (LU) | 2007-09-26 | — | — | CN | disclosed |